182 related articles for article (PubMed ID: 34142633)
1. ROS-responsive dimeric prodrug-based nanomedicine targeted therapy for gastric cancer.
Ma J; Chen Y; Liang W; Li L; Du J; Pan C; Zhang C
Drug Deliv; 2021 Dec; 28(1):1204-1213. PubMed ID: 34142633
[TBL] [Abstract][Full Text] [Related]
2. ROS-Activated homodimeric podophyllotoxin nanomedicine with self-accelerating drug release for efficient cancer eradication.
Liang B; Zhou D
Drug Deliv; 2021 Dec; 28(1):2361-2372. PubMed ID: 34747277
[TBL] [Abstract][Full Text] [Related]
3. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy.
Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J
Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764
[TBL] [Abstract][Full Text] [Related]
5. pH and ROS sequentially responsive podophyllotoxin prodrug micelles with surface charge-switchable and self-amplification drug release for combating multidrug resistance cancer.
Li C; Wang Y; Zhang S; Zhang J; Wang F; Sun Y; Huang L; Bian W
Drug Deliv; 2021 Dec; 28(1):680-691. PubMed ID: 33818237
[TBL] [Abstract][Full Text] [Related]
6. Quantitative and high drug loading of self-assembled prodrug with defined molecular structures for effective cancer therapy.
Tang J; Zeng Z; Yan J; Chen C; Liu J; Feng X
J Control Release; 2019 Aug; 307():90-97. PubMed ID: 31185233
[TBL] [Abstract][Full Text] [Related]
7. Formulation optimization of an ephrin A2 targeted immunoliposome encapsulating reversibly modified taxane prodrugs.
Huang ZR; Tipparaju SK; Kirpotin DB; Pien C; Kornaga T; Noble CO; Koshkaryev A; Tran J; Kamoun WS; Drummond DC
J Control Release; 2019 Sep; 310():47-57. PubMed ID: 31400383
[TBL] [Abstract][Full Text] [Related]
8. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
[TBL] [Abstract][Full Text] [Related]
9. A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy.
Fu D; Ni Z; Wu K; Cheng P; Ji X; Li G; Shang X
Drug Deliv; 2021 Dec; 28(1):195-205. PubMed ID: 33438472
[TBL] [Abstract][Full Text] [Related]
10. Dynamic core crosslinked camptothecin prodrug micelles with reduction sensitivity and boronic acid-mediated enhanced endocytosis: An intelligent tumor-targeted delivery nanoplatform.
Huang Y; Zhang W; Xu Y; Zhu S; Wu Y; Chen T; Xiao Y; Lu W; Zhang X; Yu J
Int J Pharm; 2020 Apr; 580():119250. PubMed ID: 32209369
[TBL] [Abstract][Full Text] [Related]
11. Cargo-Free Nanomedicine with pH Sensitivity for Codelivery of DOX Conjugated Prodrug with SN38 To Synergistically Eradicate Breast Cancer Stem Cells.
Sun N; Zhao C; Cheng R; Liu Z; Li X; Lu A; Tian Z; Yang Z
Mol Pharm; 2018 Aug; 15(8):3343-3355. PubMed ID: 29923726
[TBL] [Abstract][Full Text] [Related]
12. Selective self-induced stimulus amplification prodrug platform for inhibiting multidrug resistance and lung metastasis.
Xu C; Sun Y; Qi Y; Yu Y; He Y; Hu M; Hu Q; Wu T; Zhang D; Shang L; Deng H; Zhang Z
J Control Release; 2018 Aug; 284():224-239. PubMed ID: 29958912
[TBL] [Abstract][Full Text] [Related]
13. ROS-Responsive Polyprodrug Nanoparticles for Triggered Drug Delivery and Effective Cancer Therapy.
Xu X; Saw PE; Tao W; Li Y; Ji X; Bhasin S; Liu Y; Ayyash D; Rasmussen J; Huo M; Shi J; Farokhzad OC
Adv Mater; 2017 Sep; 29(33):. PubMed ID: 28681981
[TBL] [Abstract][Full Text] [Related]
14. A pH/ROS cascade-responsive and self-accelerating drug release nanosystem for the targeted treatment of multi-drug-resistant colon cancer.
Chang N; Zhao Y; Ge N; Qian L
Drug Deliv; 2020 Dec; 27(1):1073-1086. PubMed ID: 32706272
[TBL] [Abstract][Full Text] [Related]
15. Prodrug-based nano-delivery strategy to improve the antitumor ability of carboplatin
Lang T; Li N; Zhang J; Li Y; Rong R; Fu Y
Drug Deliv; 2021 Dec; 28(1):1272-1280. PubMed ID: 34176381
[TBL] [Abstract][Full Text] [Related]
16. Self-Activating Therapeutic Nanoparticle: A Targeted Tumor Therapy Using Reactive Oxygen Species Self-Generation and Switch-on Drug Release.
Kang RH; Kim Y; Kim JH; Kim NH; Ko HM; Lee SH; Shim I; Kim JS; Jang HJ; Kim D
ACS Appl Mater Interfaces; 2021 Jul; 13(26):30359-30372. PubMed ID: 34142813
[TBL] [Abstract][Full Text] [Related]
17. ROS-Responsive and active targeted drug delivery based on conjugated polymer nanoparticles for synergistic chemo-/photodynamic therapy.
Zhang Z; Lu Z; Yuan Q; Zhang C; Tang Y
J Mater Chem B; 2021 Mar; 9(9):2240-2248. PubMed ID: 33596297
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin Prodrug-Loaded Nanoparticles Based on Physalis Mottle Virus for Cancer Therapy.
Hu H; Steinmetz NF
Mol Pharm; 2020 Dec; 17(12):4629-4636. PubMed ID: 33186039
[TBL] [Abstract][Full Text] [Related]
19. Smart Responsive Quercetin-Conjugated Glycol Chitosan Prodrug Micelles for Treatment of Inflammatory Bowel Diseases.
Shen C; Zhao L; Du X; Tian J; Yuan Y; Jia M; He Y; Zeng R; Qiao R; Li C
Mol Pharm; 2021 Mar; 18(3):1419-1430. PubMed ID: 33522827
[TBL] [Abstract][Full Text] [Related]
20. Photosensitizer-driven nanoassemblies of homodimeric prodrug for self-enhancing activation and synergistic chemo-photodynamic therapy.
Zhang S; Wang Z; Kong Z; Wang Y; Zhang X; Sun B; Zhang H; Kan Q; He Z; Luo C; Sun J
Theranostics; 2021; 11(12):6019-6032. PubMed ID: 33897896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
